Glaucoma, Parkinson's disease and neurodegeneration

被引:0
|
作者
Balci, Sevcan Yildiz [1 ]
Eraslan, Muhsin [2 ]
Temel, Ahmet [2 ]
机构
[1] Igdir Devlet Hastanesi, Oftalmol Klin, Igdir, Turkey
[2] Marmara Univ, Tip Fak Hastanesi, Oftalmol Anabilim Dali, Ust Kaynarca, Pendik, Turkey
来源
MARMARA MEDICAL JOURNAL | 2015年 / 28卷 / 01期
关键词
Irreversible vision loss; Neurodegenerative disorders; Neuroprotective therapy;
D O I
10.5472/MMJ.2015.03691.1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glaucoma is a disease that causes irreversible vision loss characterized by progressive retinal ganglion cell (RGC) death. The mechanisms independent of intraocular pressure are also implicated in glaucomatous degeneration pathogenesis and numerous similarities exist between glaucoma and neurodegenerative diseases such as Alzheimer's and Parkinson's diseases. Although, there is a common pathway between glaucoma and neurodegenerative disorders, pathogenesis of the relationship between neurodegenerative disorders and glaucoma remains poorly undefined. Optical coherence tomography (OCT), non-invasively quantifies the thickness of the retinal nerve fiber layer (RNFL) which is effected due to RGC damage in glaucomatous patients. Recently, RNFL thickness measurements have been studied by using OCT in several neurodegenerative conditions, including Parkinson's disease. The RNFL is unique as a model of neurodegeneration where the changes in its structure is represented with axonal damage. RNFL thickness measurements are important in neurodegenerative disorders which are characterized with neuronal loss and have common pathogenesis with glaucoma. In this review, we emphasize the relationship between glaucoma, Parkinson's disease and neurodegeneration.
引用
收藏
页码:8 / 12
页数:5
相关论文
共 50 条
  • [41] Tetracycline repurposing in neurodegeneration: focus on Parkinson’s disease
    Mariza Bortolanza
    Glauce C. Nascimento
    Sergio B. Socias
    Diego Ploper
    Rosana N. Chehín
    Rita Raisman-Vozari
    Elaine Del-Bel
    Journal of Neural Transmission, 2018, 125 : 1403 - 1415
  • [42] Tetracycline repurposing in neurodegeneration: focus on Parkinson's disease
    Bortolanza, Mariza
    Nascimento, Glauce C.
    Socias, Sergio B.
    Ploper, Diego
    Chehin, Rosana N.
    Raisman-Vozari, Rita
    Del-Bel, Elaine
    JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (10) : 1403 - 1415
  • [43] Microbial BMAA and the Pathway for Parkinson's Disease Neurodegeneration
    Nunes-Costa, Daniela
    Magalhaes, Joao Duarte
    G-Fernandes, Maria
    Cardoso, Sandra Morais
    Empadinhas, Nuno
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 12
  • [44] The importance of Wnt signalling for neurodegeneration in Parkinson's disease
    Berwick, Daniel C.
    Harvey, Kirsten
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 1123 - 1128
  • [45] Parkinson's disease neurodegeneration is mediated by the gut microbiome
    Munoz Pinto, M.
    Esteves, A. R.
    de Magalhaes, J. D.
    Nunes-Costa, D.
    Candeias, E.
    Silva, D. F.
    Alarico, S.
    Pereira-Santos, A. R.
    Reis-Carneiro, D.
    Melo-Marques, I.
    Lemos, J.
    Tiago, I.
    Januario, C.
    Empadinhas, N.
    Cardoso, S. M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 : 159 - 160
  • [46] The Effect of Neurodegeneration on Visuomotor Behavior in Alzheimer's Disease and Parkinson's Disease
    de Boer, Casper
    van der Steen, Johannes
    Mattace-Raso, Francesco
    Boon, Agnita J. W.
    Pel, Johan J. M.
    MOTOR CONTROL, 2016, 20 (01) : 1 - 20
  • [47] Neurodegeneration in Alzheimer's disease and glaucoma: overlaps and missing links
    Sen, Sagnik
    Saxena, Rohit
    Tripathi, Manjari
    Vibha, Deepti
    Dhiman, Rebika
    EYE, 2020, 34 (09) : 1546 - 1553
  • [48] Neurodegeneration in Alzheimer’s disease and glaucoma: overlaps and missing links
    Sagnik Sen
    Rohit Saxena
    Manjari Tripathi
    Deepti Vibha
    Rebika Dhiman
    Eye, 2020, 34 : 1546 - 1553
  • [49] Neurodegeneration and Neuroprotection in Parkinson Disease
    Fahn S.
    Sulzer D.
    NeuroRX, 2004, 1 (1): : 139 - 154
  • [50] Alzheimer's disease and Parkinson's disease: Distinct entities or extremes of a spectrum of neurodegeneration?
    Perl, DP
    Olanow, CW
    Calne, D
    ANNALS OF NEUROLOGY, 1998, 44 (03) : S19 - S31